Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

06/03/2017 Clarity in Reporting Terminology and Definitions of Set End Points in Resistance Training 22/03/2016 Definition and classification of intraoperative complications (CLASSIC): Delphi study and pilot evaluation 19/05/2015 An introduction to standardized clinical nomenclature for dysmorphic features: the Elements of Morphology project 11/02/2015 A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints 11/02/2015 Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study 04/02/2015 Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet 04/02/2015 A consensus approach toward the standardization of back pain definitions for use in prevalence studies

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More